Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers
NP Klein, J Bartlett, B Fireman, A Rowhani-Rahbar… - …, 2013 - publications.aap.org
BACKGROUND: During the 1990s, the United States switched from combined diphtheria,
tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis …
tetanus toxoids, whole-cell pertussis (DTwP) vaccines to combined acellular pertussis …
Acellular pertussis vaccine effectiveness over time
OBJECTIVES: To determine pertussis risk by diphtheria-tetanus-acellular pertussis (DTaP)
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …
vaccination status and time since last DTaP dose. METHODS: Children born at Kaiser …
Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic
AM Acosta, C DeBolt, A Tasslimi, M Lewis… - …, 2015 - publications.aap.org
BACKGROUND: Acellular pertussis vaccines replaced whole-cell vaccines for the 5-dose
childhood vaccination series in 1997. A sixth dose of pertussis-containing vaccine, tetanus …
childhood vaccination series in 1997. A sixth dose of pertussis-containing vaccine, tetanus …
Waning protection after fifth dose of acellular pertussis vaccine in children
NP Klein, J Bartlett, A Rowhani-Rahbar… - … England Journal of …, 2012 - Mass Medical Soc
Background In the United States, children receive five doses of diphtheria, tetanus, and
acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five …
acellular pertussis (DTaP) vaccine before 7 years of age. The duration of protection after five …
Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four-to six-year-old children
ME Pichichero, KM Edwards, EL Anderson… - …, 2000 - publications.aap.org
Objective. To evaluate the safety and immunogenicity of 6 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
vaccines combined with diphtheria and tetanus toxoids (DTaP) and with 1 licensed whole …
Waning immunity to pertussis following 5 doses of DTaP
SY Tartof, M Lewis, C Kenyon, K White, A Osborn… - …, 2013 - publications.aap.org
OBJECTIVE: To assess the risk of pertussis by time since vaccination in children in
Minnesota and Oregon who received 5 doses of acellular pertussis vaccines (DTaP) …
Minnesota and Oregon who received 5 doses of acellular pertussis vaccines (DTaP) …
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15-to 20-month-old children
ME Pichichero, MA Deloria, MB Rennels… - …, 1997 - publications.aap.org
Objective. To compare the safety and immunogenicity of 12 different acellular pertussis
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
vaccines combined with diphtheria and tetanus toxoids (DTaP) with one licensed diphtheria …
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998–2001
KM Bisgard, P Rhodes, BL Connelly, D Bi, C Hahn… - …, 2005 - publications.aap.org
Background. Despite the dramatic pertussis decrease since the licensure of whole-cell
pertussis (diphtheria-tetanus toxoids-pertussis [DTP]) vaccines in the middle 1940s …
pertussis (diphtheria-tetanus toxoids-pertussis [DTP]) vaccines in the middle 1940s …
The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada
JA Bettinger, SA Halperin, G De Serres… - The Pediatric …, 2007 - journals.lww.com
Background: Between July 1997 and April 1998, universal childhood immunization
programs in Canada changed from using a whole-cell pertussis to a 5-component acellular …
programs in Canada changed from using a whole-cell pertussis to a 5-component acellular …
Duration of protection after first dose of acellular pertussis vaccine in infants
HE Quinn, TL Snelling, KK Macartney… - Pediatrics, 2014 - publications.aap.org
OBJECTIVE: Data on the effectiveness of the diphtheria–tetanus–acellular pertussis (DTaP)
vaccine in the first 4 years of life are sparse. We evaluated the vaccine effectiveness (VE) of …
vaccine in the first 4 years of life are sparse. We evaluated the vaccine effectiveness (VE) of …